Artivion: Innovation at Heart – How the MedTech Company is Conquering the Market for Aortic Diseases
Reading Time: 3 minutes
Artivion specializes in the treatment of aortic diseases, a market that is becoming increasingly important due to an aging population and the rising prevalence of cardiovascular diseases. Through consistent investments in research and development as well as strategic acquisitions such as those of JOTEC and Ascyrus Medical, Artivion continuously expands its product offerings. Artivion is already well positioned internationally and sells its products in over 100 countries worldwide. Artivion (NYSE: AORT) is a leading medical technology...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
